Back
Apellis Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
APLS
Apellis Pharmaceuticals
Last Price:
30.76
Seasonality Move:
16.11%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.97 | Buy |
| 20-day SMA: | 28.22 | Buy |
| 50-day SMA: | 29.11 | Buy |
| 200-day SMA: | 42.36 | Sell |
| 8-day EMA: | 28.48 | Buy |
| 20-day EMA: | 28.34 | Buy |
| 50-day EMA: | 29.88 | Buy |
| 200-day EMA: | 39.46 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 59.23 | Buy |
| Chaikin Money Flow: | 2322513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.9 - 29.12) | Buy |
| Bollinger Bands (100): | (28.55 - 38.61) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 30.77 while APLS 8-day simple moving average is 27.97, which is a Buy signal.
- The stock price of APLS is 30.77 while Apellis Pharmaceuticals 20-day SMA is 28.22, which makes it a Buy.
- Apellis Pharmaceuticals 50-day simple moving average is 29.11 while APLS share price is 30.77, making it a Buy technically.
- APLS stock price is 30.77 and Apellis Pharmaceuticals 200-day simple moving average is 42.36, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
48
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $30.77. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
3.83B
Price in USD:
30.77
Share Volume:
2.68M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
24.34
Sell
48
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 30.77 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 30.77 while APLS 8-day exponential moving average is 28.48, which is a Buy signal.
- The stock price of APLS is 30.77 while Apellis Pharmaceuticals 20-day EMA is 28.34, which makes it a Buy.
- Apellis Pharmaceuticals 50-day exponential moving average is 29.88 while APLS share price is 30.77, making it a Buy technically.
- APLS stock price is 30.77 and Apellis Pharmaceuticals 200-day simple moving average is 39.46, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 59.23, which suggest Apellis Pharmaceuticals is overbought
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (26.9 - 29.12), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (28.55 - 38.61), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.